Clinical Needs Sample Clauses

Clinical Needs. 3.3.1 Current Scottish Government policy for the design and development of services to care for the Mental Health of Children and Young people was published in the National Framework3 in 2005. This National Framework defined the levels of care and are summarised in Figure 1 below: Figure 1: Description of CAMHS service tiers based on levels of need Tertiary level services such as inpatient units, highly specialised outpatient teams and day units, Assessment and treatment is the core function. Involves - Child and Adolescent Psychiatrists, Clinical Child Psychologists, Nurse (community and in/pts) Child Psychotherapists, Physiotherapists, Occupational therapists, Speech & language therapists, Art, music & Drama therapists, Social Workers, Dietician, Voluntary Agencies. A specialised service for more severe, complex or persistent mental health problems up to a certain level of need Assessment and treatment is the core function. Involves - Child and adolescent psychiatrists, Clinical Child Psychologists Nurse (community and inpatients) Child psychotherapists Occupational therapists, Speech & language therapists, Dieticians, Art, music & drama therapists, Social workers and Voluntary agencies. A level of service provided by uni-professional groups, which relate to each other through a network rather than a team. Functions include assessment, care and treatment for children and young people and consultation and advice to professionals in Tier 1. Involves - Practitioners with a special interest, Clinical child psychiatrists, Paediatricians (especially community), Educational Psychologists, Child & Adolescent Psychiatrists, Social Workers, Voluntary agencies, Primary Mental Health Workers. A primary level of service provided within universal services and including mental health promotion, general advice and identification of mental health problems early in their development. Each NHS Board area has available a variety of services provided by a variety of practitioners, including: GPs, AHPs, Public Health Nurses, Teachers, Social Workers, Voluntary Agencies 3 (2005) “The Mental Health of Children and Young People: A Framework for Promotion, Prevention and Care” Oct, 2005, Scottish Executive, Edinburgh, Astron B43221 10/05
Sample 1
AutoNDA by SimpleDocs
Clinical Needs 
Sample 1

Related to Clinical Needs

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Curriculum Vitae (a) The Chief Librarian shall maintain a curriculum vita for each Librarian. It is the Librarian’s responsibility to ensure that the curriculum vita on file is kept current. Members shall prepare their curriculum vita with the advice and assistance of their Chief Librarian. Members may revise their curriculum vita at any time.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Trials The Ship shall run the following test and trials:

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Clinical Management for Behavioral Health Services (CMBHS) System The CMBHS is the official record of documentation by System Agency. Grantee shall:

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

Time is Money Join Law Insider Premium to draft better contracts faster.